Advertisement
Landec Corporation

Landec Corporation (LNDC) Stock Overview

Explore Landec Corporation’s financial performance, market position, analyst ratings, and future outlook.

LNDCNASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$8.76
$0.32(3.52%)
U.S. Market opens in 64h 45m
Advertisement

Landec Corporation (LNDC)

Meyka AI Score

Z

Key Financials

Market Cap263.6M
P/E Ratio-10.51
EPS (TTM)$-2.17
ROE-9.05%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

LNDC Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Landec Corporation (LNDC) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -10.51 and a market capitalization of 263.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
22.69%
3-Month Change
-3.52%
6-Month Change
-21.99%
Year-to-Date (YTD) Change
N/A
1-Year Change
-23.96%
3-Year Change
-22.68%
5-Year Change
-33.38%
All-Time (Max) Change
-31.29%

Contact Information

16503061650
5201 Great America Pkwy Ste 232, Santa Clara, CA, 93455

Company Facts

6,890 Employees
IPO DateFeb 16, 1996
CountryUS

Frequently Asked Questions